AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Activity

19 hedge funds and large institutions have $28M invested in Avalo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
1
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$6K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$95K
2
Morgan Stanley
2
Morgan Stanley
New York
$62.6K
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$2K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$220K
2
NCM
2
Nantahala Capital Management
Connecticut
$2.73M
3
Goldman Sachs
3
Goldman Sachs
New York
$167K
4
UBS Group
4
UBS Group
Switzerland
$31.1K
5
BNP Paribas Financial Markets
5
BNP Paribas Financial Markets
France
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
26
Parallel Advisors
California
$5 – – –
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
– -$2.38K -3 Closed
1
2